Hydrolysis of intact and Cys‐Phe‐cleaved human atrial natriuretic peptide in vitro by human tissue kallikrein
- 3 March 1991
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 196 (2) , 281-286
- https://doi.org/10.1111/j.1432-1033.1991.tb15815.x
Abstract
Atrial natriuretic peptide (ANP) is a 28-amino-acid hormone involved in the regulation of fluid balance. In circulation, the proteolytic inactivation of ANP has been demonstrated to involve both membrane metalloendopeptidase and an aprotonin-sensitive activity, probably corresponding to kallikrein [Vanneste, Y., Pauwels, S., Lambotte, L., Michel, A., Dimaline, R. & Deschodt-Lanckman, M. (1990) Biochem. J. 269, 801-806]. In the present study, we focused on the aprotinin-sensitive pathway of ANP metabolism. In order to identify the cleavage sites recognized by kallikrein within the sequence of the hormone, tissue kallikrein was purified to homogeneity from human urine and the degradation of human ANP by the enzyme preparation was studied. Our results demonstrate that both intact and Cys7-Phe8-cleaved ANP, the initial metabolite produced in circulation by the metallo-endopeptidase, are substrates in vitro for purified tissue kallikrein. However, the Cys-Phe-cleaved peptide was degraded approximately fourfold faster than the intact hormone by the purified enzyme. The first degradation step of ANP by tissue kallikrein involves two cleavages occurring at the bonds Arg3-Arg4 and Gly16-Ala17, generating an inactive, open-ring metabolite. Incubation of ANP for a longer period with the enzyme led to the generation of several additional degradation fragments. Ten peaks were separated by HPLC and characterized by amino acid analysis. The results allowed the identification of a total of eight peptide bonds susceptible to hydrolysis by tissue kallikrein in the sequence of ANP: Arg3-Arg4, Ser5-Ser6, Cys7-Phe8, Arg11-Met12, Gly16-Ala17, Gly20-Leu21, Ser25-Phe26 and Arg27-Tyr28. These results indicate that the aprotinin-sensitive activity involved in the metabolism of ANP in circulation could correspond to tissue kallikrein. However, clear identification of ANP as a novel physiological substrate of the enzyme will need further investigation.Keywords
This publication has 33 references indexed in Scilit:
- Tissue Kallikreins and Kinins: Regulation and Roles in Hypertensive and Diabetic DiseasesAnnual Review of Pharmacology and Toxicology, 1989
- Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in manLife Sciences, 1986
- Nature of atrial natriuretic polypeptide in rat brainBiochemical and Biophysical Research Communications, 1986
- Kinin-forming activity in rat brainNeurochemistry International, 1985
- Isolation of tissue kallikrein in rat spleen by monoclonal antibody-affinity chromatographyBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Atrial natriuretic factor and urinary kallikrein in the rat: antagonistic factors?Canadian Journal of Physiology and Pharmacology, 1984
- Rat atrial natriuretic factor: Complete amino acid sequence and disulfide linkage essential for biological activityBiochemical and Biophysical Research Communications, 1984
- A Met-enkephalin-containing-peptide, BAM 22P, as a novel substrate for glandular kallikreinsBiochemical and Biophysical Research Communications, 1983
- Isolation of an Enzymatically Active Glandular Kallikrein from Human Plasma by Immunoaffinity ChromatographyHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976